Cabalit, Trista Danea S.

HRN: 21-41-55  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2022
CEFUROXIME 750MG (VIAL)
06/05/2022
06/11/2022
IV
1. 5G
Q8h
UTI
06/05/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/05/2022
06/11/2022
IV
500mg
Q8h
S/P CS With IUD Insertion
Waiting Final Action 
06/06/2022
CEFUROXIME 500MG (TAB)
06/06/2022
06/11/2022
PO
509mg
BID
S/P CS
Waiting Final Action 
06/06/2022
METRONIDAZOLE 500MG (TAB)
06/06/2022
06/11/2022
PO
500mg
TID
S/P CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: